Inspire Medical Systems Inc (INSP)
202.48
-4.62
(-2.23%)
USD |
NYSE |
Sep 27, 16:00
202.35
-0.13
(-0.06%)
After-Hours: 20:00
Inspire Medical Systems SG&A Expense (Annual): 451.96M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 451.96M |
| December 31, 2022 | 320.69M |
| December 31, 2021 | 202.62M |
| December 31, 2020 | 127.87M |
| December 31, 2019 | 90.46M |
| Date | Value |
|---|---|
| December 31, 2018 | 53.53M |
| December 31, 2017 | 32.36M |
| December 31, 2016 | 22.68M |
| December 31, 2015 | 17.92M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
90.46M
Minimum
2019
451.96M
Maximum
2023
238.72M
Average
202.62M
Median
2021
SG&A Expense (Annual) Benchmarks
| Nevro Corp | 334.70M |
| Axonics Inc | 235.32M |
| Inari Medical Inc | 361.06M |
| Electromed Inc | 34.49M |
| Myomo Inc | 18.78M |